Interesting discussion on this important topic – Summary International Expert Meeting on breast implant-associated lymphoma
RIVM – Summary International Expert Meeting on breast implant-associated lymphoma
More from Breast Implant-Associated Anaplastic Large Cell Lymphoma BIA-ALCLMore posts in Breast Implant-Associated Anaplastic Large Cell Lymphoma BIA-ALCL »
- EU – SCHEER – Minutes of the Working Group meeting on safety of breast implants in relation to anaplastic large cell lymphoma (BIA-ALCL) of 15 January 2020
- SCHEER Safety of breast implants WG – minutes of 4 November 2019 meeting
- EU – Minutes of the 24 July 2019 SCHEER Working Group on safety of breast implants in relation to anaplastic large cell lymphoma (BIA-ALCL) meeting
- TGA – Australian regulatory action on breast implants and breast tissue expanders
- The FDA Takes Action to Protect Patients from Risk of Certain Textured Breast Implants; Requests Allergan Voluntarily Recall Certain Breast Implants and Tissue Expanders from the Market: FDA Safety Communication
More from Breast ImplantsMore posts in Breast Implants »
- EU – SCHEER – Minutes of the Working Group meeting on safety of breast implants in relation to anaplastic large cell lymphoma (BIA-ALCL) of 15 January 2020
- SCHEER Safety of breast implants WG – minutes of 4 November 2019 meeting
- US FDA Draft Guidance – Breast Implants – Certain Labeling Recommendations to Improve Patient Communication
- EU – Minutes of the 24 July 2019 SCHEER Working Group on safety of breast implants in relation to anaplastic large cell lymphoma (BIA-ALCL) meeting
- TGA – Current status of breast implant products in Australia
More from National Institute for Public Health and the Environment - RIVMMore posts in National Institute for Public Health and the Environment - RIVM »
Be First to Comment